Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-06

Clinical Trial Update: Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating cisplatin-based chemotherapy followed by maintenance avelumab in upper tract urothelial carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avelumab (avelumab)
  • CISPLATIN (cisplatin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Upper Tract Urothelial Carcinoma | Phase 2 | Status: RECRUITING